Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-14
2007-08-14
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S387000, C548S304400, C548S306100
Reexamination Certificate
active
10922362
ABSTRACT:
The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.
REFERENCES:
patent: 4499295 (1985-02-01), Mueller et al.
patent: 5374623 (1994-12-01), Zimmerman et al.
patent: 5574064 (1996-11-01), Shibata et al.
patent: 5691368 (1997-11-01), Peet et al.
patent: 5723469 (1998-03-01), Shibata et al.
patent: 5849711 (1998-12-01), Tung et al.
patent: 5858982 (1999-01-01), Tung et al.
patent: 5859025 (1999-01-01), Wagner et al.
patent: 5916887 (1999-06-01), Singh et al.
patent: 5998470 (1999-12-01), Halbert et al.
patent: 6004933 (1999-12-01), Spruce et al.
patent: 6030946 (2000-02-01), Klaus et al.
patent: 6057362 (2000-05-01), Yamashita
patent: 6232342 (2001-05-01), Carr et al.
patent: 6274336 (2001-08-01), Abdel-Meguid et al.
patent: 6331542 (2001-12-01), Carr et al.
patent: 6353017 (2002-03-01), Altmann et al.
patent: 6369077 (2002-04-01), Marquis et al.
patent: 6395897 (2002-05-01), Cywin et al.
patent: 6420364 (2002-07-01), Emmanuel et al.
patent: 6455502 (2002-09-01), Bryant et al.
patent: 2004/0127426 (2004-07-01), Graupe et al.
patent: WO 98/00171 (1998-01-01), None
patent: WO 98/50534 (1998-11-01), None
patent: WO 00/48993 (2000-08-01), None
patent: WO 00/51998 (2000-09-01), None
patent: WO 01/09110 (2001-02-01), None
patent: WO 01/19816 (2001-03-01), None
patent: WO 02/14314 (2002-02-01), None
patent: WO 02/14317 (2002-02-01), None
patent: WO 02/14315 (2002-03-01), None
patent: WO 02/051983 (2002-07-01), None
patent: WO 02/069901 (2002-09-01), None
patent: WO 02/070517 (2002-09-01), None
patent: WO 02/070519 (2002-09-01), None
patent: WO 03/013518 (2003-02-01), None
patent: WO 03/020287 (2003-03-01), None
Bania, J. et al.: “Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs” PNAS; vol. 100, No. 11; pp. 6664-6669 (May 27, 2003).
Alper Phillip B.
Karanewsky Donald S.
Liu Hong
Anderson Rebecca
Chung Susannah
IRM LLC
The Genomics Institute of the Novartis Research Foundation
Tongco Wu Emily
LandOfFree
Inhibitors of cathepsin S does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of cathepsin S, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of cathepsin S will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3872428